Roubaix Capital, LLC Trans Medics Group, Inc. Transaction History

Roubaix Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$17.75 - $47.82 $3.61 Million - $9.72 Million	-203,195 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$11.91 - $19.9 $526,957 - $880,475	44,245 Added 27.84%	203,195 $4.04 Million
Q3 2020 Nov 03, 2020	SELL	$13.78 - $18.84 $645,028 - $881,881	-46,809 Reduced 22.75%	158,950 $2.19 Million
Q2 2020 Jul 28, 2020	SELL	$11.66 - $18.26 $310,494 - $486,245	-26,629 Reduced 11.46%	205,759 $3.69 Million
Q1 2020 Apr 15, 2020	SELL	$10.5 - $20.2 $336,525 - $647,410	-32,050 Reduced 12.12%	232,388 $2.81 Million
Q4 2019 Jan 15, 2020	BUY	$16.61 - $21.64 $844,734 - $1.1 Million	50,857 Added 23.81%	264,438 $5.03 Million
Q3 2019 Oct 08, 2019	BUY	$20.27 - $28.93 $859,610 - $1.23 Million	42,408 Added 24.77%	213,581 $5.07 Million
Q2 2019 Jul 30, 2019	BUY	$22.36 - $30.41 $3.83 Million - $5.21 Million	171,173 New	171,173 $4.96 Million

398

31.9M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.76B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Roubaix Capital, LLC with notifications on news.